Michael Sweeney, M.D.
Chief Medical Officer and Vice President, Research and Development
Dr. Sweeney joined Depomed as vice president of Product Development in December 2007. Before joining Depomed, Dr. Sweeney was vice president of Medical Affairs at CV Therapeutics, where he built the Medical Affairs Department to enable the commercial preparation and successful launch of Ranexa® in 2006. Prior to CV Therapeutics, Dr. Sweeney spent 11 years at Pfizer Pharmaceuticals in New York and the U.K. where he held a variety of senior-level medical and marketing positions, including director of Marketing, Viagra Worldwide Team and Global Urology Medical Group Leader for Pfizer’s urological products Viagra, Cardura and Detrol. Prior to Pfizer, he served as a senior clinical pharmacologist and a medical advisor at Zeneca PLC. Dr. Sweeney received his M.D. degree from Manchester University in the U.K. together with post graduate diplomas in Pharmaceutical Medicine and Pharmacoepidemiology, the latter from the University of London. He also is a Fellow of the Royal College of Physicians of Edinburgh.